| 2019 | | 2018 Guidelines for the management of dyslipidemia | 김혜진 |
| 2023 | | 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association | 김대중, 김혜진 |
| 2022 | | A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia | 최소연 |
| 2022 | | A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy | 양형모 |
| 2012 | | C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome | 이관우 |
| 2023 | | Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus | 김혜진 |
| 2015 | | Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry. | 최소연 |
| 2024 | | Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study | 김혜진 |
| 2014 | | Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study. | 신준한 |
| 2020 | | Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia | 최소연 |
| 2016 | | Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) | 박진선, 신준한 |
| 2024 | | Efficacy and Safety of Metformin and AtorvastatinCombination Therapy vs. Monotherapy with EitherDrug in Type 2 Diabetes Mellitus and DyslipidemiaPatients (ATOMIC): Double-Blinded RandomizedControlled Trial | 김대중 |
| 2020 | | Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial | 김혜진 |
| 2018 | | Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: A cross-sectional analysis | 부선주 |
| 2013 | | Healthy range of serum alanine aminotransferase and its predictive power for cardiovascular risk in children and adolescents. | 황진순 |
| 2020 | | Hyperreflective foci in diabetic macular edema with serous retinal detachment: association with dyslipidemia | 김영호, 변혜은, 이기황, 이승엽, 정유리 |
| 2015 | | PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. | 김대중 |
| 2023 | | Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia | 신준한 |
| 2005 | | Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. | 조남한 |
| 2016 | | Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database | 박래웅, 신승수, 윤덕용, 임홍석, 최용준 |
| 2011 | | The Relationship between coronary artery calcification as assessed by multi-detector computed tomography and arterial stiffness. | 박진선, 신준한, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
| 2020 | | Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | 김대중 |
